ARS Pharmaceuticals
IPO
- Headquarters
- San Diego, California
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- ars-pharma.com
- Total Funding
- $75.0M
- Last Round
- $55.0M Series DAug 2021
About
Develops and commercializes neffy, an FDA-approved needle-free epinephrine nasal spray for treating severe allergic reactions and anaphylaxis.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account